Azacitidine With Carboplatin and Paclitaxel for Newly Diagnosed Ovarian Cancer

This study has been withdrawn prior to enrollment.
(No enrollment. Unable to recruit due to lack of eligible patients.)
Sponsor:
Collaborator:
Celgene Corporation
Information provided by (Responsible Party):
Loyola University
ClinicalTrials.gov Identifier:
NCT00842582
First received: February 11, 2009
Last updated: November 1, 2016
Last verified: November 2016
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Study Completion Date: March 2011
  Primary Completion Date: March 2011 (Final data collection date for primary outcome measure)